Profil
Dr. Richard E.
Gilbert is a Member-Scientific Advisory Board at Fibrotech Therapeutics Pty Ltd. and a Professor at University of Toronto.
Dr. Gilbert was previously employed as a Principal by GlaxoSmithKline, Inc., a Principal by Eli Lilly & Co., and a Principal by Merck & Co., Inc.
Postes actifs de Richard Ernest Gilbert
| Sociétés | Poste | Début |
|---|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2011 |
Anciens postes connus de Richard Ernest Gilbert
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fibrotech Therapeutics Pty Ltd.
Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops novel drugs candidates for the treatment of the fibrosis prevalent | Health Technology |
















